Correction: Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting

QR Code

Correction: Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting

Enregistré dans:

Détails bibliographiques
Format:	article
Langue:	EN
Publié:	BMJ Publishing Group 2021
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/df218bd6280e4292b87ff353a9599502
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting
par: Torsten Tonn, et autres
Publié: (2021)

Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)
par: Vidhi Khanna, et autres
Publié: (2021)

How Can We Engineer CAR T Cells to Overcome Resistance?
par: Glover M, et autres
Publié: (2021)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
par: Sergey Kulemzin, et autres
Publié: (2021)

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
par: Erica L. Heipertz, et autres
Publié: (2021)

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.
par: Dieter Mielke, et autres
Publié: (2021)

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection
par: Dieter Mielke, et autres
Publié: (2021)

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
par: Lara Herrera, et autres
Publié: (2021)

Overcoming Microalgae Harvesting Barrier by Activated Algae Granules
par: Olga Tiron, et autres
Publié: (2017)

Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells
par: Shin Yi Tang, et autres
Publié: (2021)

Production of human CAR-NK cells with lentiviral vectors and functional assessment in vitro
par: Ana L. Portillo, et autres
Publié: (2021)

Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9
par: Lintao Liu, et autres
Publié: (2020)

CAR-T: a potential gene carrier targeting solid tumor immune microenvironment
par: Minjie Wang, et autres
Publié: (2021)

MAIT cells regulate NK cell-mediated tumor immunity
par: Emma V. Petley, et autres
Publié: (2021)

Inability to Culture <named-content content-type="genus-species">Pneumocystis jirovecii</named-content>
par: Yueqin Liu, et autres
Publié: (2018)

Is perceived inability to procreate associated with life satisfaction? Evidence from a German panel study
par: Julia McQuillan, et autres
Publié: (2022)

HIV-1 Envelope Glycoproteins Proteolytic Cleavage Protects Infected Cells from ADCC Mediated by Plasma from Infected Individuals
par: Jérémie Prévost, et autres
Publié: (2021)

NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
par: Taiga Seki, et autres
Publié: (2021)

HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads.
par: Jennifer Mabuka, et autres
Publié: (2012)

CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
par: Pauline Thomas, et autres
Publié: (2021)

Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
par: Christopher Sloas, et autres
Publié: (2021)

FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
par: Jae Hong Im, et autres
Publié: (2020)

The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors
par: Rodion A. Velichinskii, et autres
Publié: (2021)

Mating can initiate stable RNA silencing that overcomes epigenetic recovery
par: Sindhuja Devanapally, et autres
Publié: (2021)

Engineering the chloroplast targeted malarial vaccine antigens in Chlamydomonas starch granules.
par: David Dauvillée, et autres
Publié: (2010)

Reply to Liu et al., “Inability To Culture <named-content content-type="genus-species">Pneumocystis jirovecii</named-content>”
par: Verena Schildgen, et autres
Publié: (2018)

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
par: Samuel Y. Ng, et autres
Publié: (2018)

CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells
par: Mario Bunse, et autres
Publié: (2021)

Formulation and Evaluation of Tablets Compressed from Granules Prepared by Thermoplastic Granulation
par: Kľoc D., et autres
Publié: (2021)

Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy
par: Yu-Chen Wang, et autres
Publié: (2021)

Introduced species that overcome life history tradeoffs can cause native extinctions
par: Jane A. Catford, et autres
Publié: (2018)

Post-stroke fatigue: A factor associated with inability to return to work in patients <60 years-A 1-year follow-up.
par: Nicole Anna Rutkowski, et autres
Publié: (2021)

Emerging Approaches for Solid Tumor Treatment Using CAR-T Cell Therapy
par: Hyunmin Chung, et autres
Publié: (2021)

NK-like T cells and plasma cytokines, but not anti-viral serology, define immune fingerprints of resilience and mild disability in exceptional aging.
par: Abbe N Vallejo, et autres
Publié: (2011)

Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles
par: Donghyun Lee, et autres
Publié: (2022)

Unifying heterogeneous expression data to predict targets for CAR-T cell therapy
par: Patrick Schreiner, et autres
Publié: (2021)

Innovation in services and the internationalization of services SMEs: challenges and the policy spheres in which they can be overcome
par: Rodríguez, Luisa
Publié: (2018)

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
par: Yong Liang, et autres
Publié: (2018)

The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy
par: Hamilton G, et autres
Publié: (2021)

Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
par: Dana S. Neel, et autres
Publié: (2017)